Search Results - "RESHEDKO, Galina"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial by FitzGerald, J Mark, Barker, Peter, Goldman, Mitchell, Tolcachier, Alberto, Otaola, María, Arce, German, Saez, Maria Salazan, Peters, Matthew, Gibson, Peter, Thien, Francis, Bardin, Philip, Hew, Mark, Pez, Andreia, Metev, Hristo, Ivanov, Yavor, Peneva, Marinka, Dorscheid, Delbert, Veverka, Josef, Zindr, Vladimir, Devouassoux, Gilles, Taille, Camille, Goupil, Francois, Keller, Claus, Kirschner, Joachim, Beck, Ekkehard, Dichmann, Rolf, Overlack, Axel, Hoffmann, Martin, Rabe, Klaus, Deckelmann, Regina, Welte, Tobias, Shimoda, Terufumi, Nagakura, Toshikazu, Takahashi, Hisaho, Haida, Michiko, Kimura, Goro, Shijyubo, Noriharu, Tanaka, Akihiko, Ohdaira, Tetsuro, Takahashi, Toshiki, Miki, Hiroshi, Diaz, Javier, Felix, Efrain, Daly, Alejandro, Estrella, Rolando, Springer, Ewa, Kwaśniewski, Artur, Rybicka-Liszewska, Elżbieta, Bodzenta-Łukaszyk, Anna, Mihaescu, Traian, Apti, Ghiulten, Trailescu, Ana, Sokurenko, Sergei, Ilyashevich, Inna, Stitsenko, Irina, Goncharova, Svetlana, Ezhov, Andrey, Izmozherova, Nadezhda, Molotkov, Artem, Pavlysh, Elena, Chistyakov, Valery, Bruning, Axel, Lee, Sang Haak, Lee, Sang Pyo, Yoo, Kwang Ha, Yoon, Hyoungkyu, Arias Guillen, Miguel, Sánchez-Toril López, Fernando, García-Cosio Piqueras, Borja, Valero Santiago, Antonio Luis, Bjermer, Leif, Gemicioglu, Bilun, Arinc, Sibel, Iashyna, Liudmyla, Mostovoy, Yuriy, Ostrovskyy, Mykola, Krakhmalova, Olena, Gavrysyuk, Volodymyr, Win, Thida, Babu, Suresh, Zwetchkenbaum, John, Bleecker, Eugene, Alpizar, Sady, Rodriguez, Hector, Pouzar, Joe, Davis, Enrique, Karimjee, Najmuddin, Shaikh, Zeeshan, Nish, William, Alvarez, German, Parikh, Purvi, Perez, Guido, Chupp, Geoffrey, Tarpay, Martha, Merchant, Rajan, Shapero, Paul, Moss, Mark, Boyd, Amy, Johnson II, Thomas, Ngo, Chau

    Published in The lancet respiratory medicine (01-01-2019)
    “…Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody that has been shown to safely reduce exacerbations and improve lung function…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5